Zurich Insurance Group (ZURN) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
17 Nov, 2026Executive summary
Record BOP of $7.38bn, up 21% YoY; net income attributable to shareholders rose 10% to $4.35bn and BOPAT ROE reached 23.1%.
Reported diluted EPS was $29.73, up 12%; adjusted EPS rose 20% to $38.5, excluding long-term market assumptions for net capital gains.
Results reflected strength across P&C, Life and Farmers, with a 94.5% P&C combined ratio and estimated SST of 233%.
Financial highlights
Insurance revenue was $56.1bn versus $50.8bn; net income attributable to shareholders was $4.35bn versus $3.96bn.
P&C gross written premiums rose 9% like-for-like and 7% in USD; insurance revenue increased 9% like-for-like and 8% in USD.
P&C BOP was $3.893bn, up 7% reported and 10% in local currencies; Life BOP reached a record $2.060bn, up 39%.
Net capital losses were $1.4bn, including a one-time $0.4bn loss tied to the Farmers Life reinsurance transaction; restructuring costs were $0.3bn.
Operating cash flow was $7.35bn versus $5.04bn; cash remittances totaled $4.8bn and proposed dividend and planned buyback represented ~100% of FY-23 payout on adjusted EPS.
Outlook and guidance
FY-23–25 EPS CAGR is expected to exceed 10%, above the prior 8% target.
FY-24 P&C insurance revenue is expected to grow at a mid-single-digit rate; investment income should benefit from reinvestment yields above book yields.
FY-24 Life BOP is expected to be at least in line with FY-23’s record level; Farmers Exchanges GWP growth is expected in the mid-single digits, with FMS MGEP margin at 7.0%.
FY-24 Farmers Re BOP reflects a 10.0% all-lines quota share from Dec. 31, 2023; Farmers Life is expected to deliver low-single-digit USD BOP.
Group Functions and Operations net expenses are forecast at $800–850m and the effective tax rate at 25–27%; Pillar II implementation was not expected to materially affect results or position.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022